Cargando…

DFFNDDS: prediction of synergistic drug combinations with dual feature fusion networks

Drug combination therapies are promising clinical treatments for curing patients. However, efficiently identifying valid drug combinations remains challenging because the number of available drugs has increased rapidly. In this study, we proposed a deep learning model called the Dual Feature Fusion...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Mengdie, Zhao, Xinwei, Wang, Jingyu, Feng, Wei, Wen, Naifeng, Wang, Chunyu, Wang, Junjie, Liu, Yun, Zhao, Lingling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022091/
https://www.ncbi.nlm.nih.gov/pubmed/36927504
http://dx.doi.org/10.1186/s13321-023-00690-3
_version_ 1784908652207931392
author Xu, Mengdie
Zhao, Xinwei
Wang, Jingyu
Feng, Wei
Wen, Naifeng
Wang, Chunyu
Wang, Junjie
Liu, Yun
Zhao, Lingling
author_facet Xu, Mengdie
Zhao, Xinwei
Wang, Jingyu
Feng, Wei
Wen, Naifeng
Wang, Chunyu
Wang, Junjie
Liu, Yun
Zhao, Lingling
author_sort Xu, Mengdie
collection PubMed
description Drug combination therapies are promising clinical treatments for curing patients. However, efficiently identifying valid drug combinations remains challenging because the number of available drugs has increased rapidly. In this study, we proposed a deep learning model called the Dual Feature Fusion Network for Drug–Drug Synergy prediction (DFFNDDS) that utilizes a fine-tuned pretrained language model and dual feature fusion mechanism to predict synergistic drug combinations. The dual feature fusion mechanism fuses the drug features and cell line features at the bit-wise level and the vector-wise level. We demonstrated that DFFNDDS outperforms competitive methods and can serve as a reliable tool for identifying synergistic drug combinations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13321-023-00690-3.
format Online
Article
Text
id pubmed-10022091
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-100220912023-03-18 DFFNDDS: prediction of synergistic drug combinations with dual feature fusion networks Xu, Mengdie Zhao, Xinwei Wang, Jingyu Feng, Wei Wen, Naifeng Wang, Chunyu Wang, Junjie Liu, Yun Zhao, Lingling J Cheminform Research Drug combination therapies are promising clinical treatments for curing patients. However, efficiently identifying valid drug combinations remains challenging because the number of available drugs has increased rapidly. In this study, we proposed a deep learning model called the Dual Feature Fusion Network for Drug–Drug Synergy prediction (DFFNDDS) that utilizes a fine-tuned pretrained language model and dual feature fusion mechanism to predict synergistic drug combinations. The dual feature fusion mechanism fuses the drug features and cell line features at the bit-wise level and the vector-wise level. We demonstrated that DFFNDDS outperforms competitive methods and can serve as a reliable tool for identifying synergistic drug combinations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13321-023-00690-3. Springer International Publishing 2023-03-16 /pmc/articles/PMC10022091/ /pubmed/36927504 http://dx.doi.org/10.1186/s13321-023-00690-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xu, Mengdie
Zhao, Xinwei
Wang, Jingyu
Feng, Wei
Wen, Naifeng
Wang, Chunyu
Wang, Junjie
Liu, Yun
Zhao, Lingling
DFFNDDS: prediction of synergistic drug combinations with dual feature fusion networks
title DFFNDDS: prediction of synergistic drug combinations with dual feature fusion networks
title_full DFFNDDS: prediction of synergistic drug combinations with dual feature fusion networks
title_fullStr DFFNDDS: prediction of synergistic drug combinations with dual feature fusion networks
title_full_unstemmed DFFNDDS: prediction of synergistic drug combinations with dual feature fusion networks
title_short DFFNDDS: prediction of synergistic drug combinations with dual feature fusion networks
title_sort dffndds: prediction of synergistic drug combinations with dual feature fusion networks
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022091/
https://www.ncbi.nlm.nih.gov/pubmed/36927504
http://dx.doi.org/10.1186/s13321-023-00690-3
work_keys_str_mv AT xumengdie dffnddspredictionofsynergisticdrugcombinationswithdualfeaturefusionnetworks
AT zhaoxinwei dffnddspredictionofsynergisticdrugcombinationswithdualfeaturefusionnetworks
AT wangjingyu dffnddspredictionofsynergisticdrugcombinationswithdualfeaturefusionnetworks
AT fengwei dffnddspredictionofsynergisticdrugcombinationswithdualfeaturefusionnetworks
AT wennaifeng dffnddspredictionofsynergisticdrugcombinationswithdualfeaturefusionnetworks
AT wangchunyu dffnddspredictionofsynergisticdrugcombinationswithdualfeaturefusionnetworks
AT wangjunjie dffnddspredictionofsynergisticdrugcombinationswithdualfeaturefusionnetworks
AT liuyun dffnddspredictionofsynergisticdrugcombinationswithdualfeaturefusionnetworks
AT zhaolingling dffnddspredictionofsynergisticdrugcombinationswithdualfeaturefusionnetworks